BioNTech SE (BNTX) EBITDA Margin Growth (1y) (2019 - 2025)
BioNTech SE (BNTX) EBITDA Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn | -4,806.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,806.00 |
| Sep 30, 2025 | -393.00 |
| Jun 30, 2025 | 55,860.00 |
| Mar 31, 2025 | -2,181.00 |
| Dec 31, 2024 | -2,309.00 |
| Sep 30, 2024 | -732.00 |
| Jun 30, 2024 | -41,484.00 |
| Mar 31, 2024 | -32,161.00 |
| Dec 31, 2023 | -4,139.00 |
| Sep 30, 2023 | -8,403.00 |
| Jun 30, 2023 | -48,458.00 |
| Mar 31, 2023 | -3,436.00 |
| Dec 31, 2022 | -798.00 |
| Sep 30, 2022 | 1,460.00 |
| Jun 30, 2022 | 6,960.00 |
| Mar 31, 2022 | 446.00 |
| Dec 31, 2021 | 8,495.00 |
| Sep 30, 2021 | -19,855.00 |
| Jun 30, 2021 | -11,463.00 |
| Mar 31, 2021 | -13,293.00 |